228 studies found for:    "Anaplastic oligodendroglioma"
Show Display Options
Rank Status Study
21 Completed Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
22 Active, not recruiting Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
23 Recruiting Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Conditions: Medulloblastoma;   Astrocytoma, Grade III;   Glioblastoma;   Anaplastic Astrocytoma;   Brain Stem Neoplasms, Malignant;   Oligodendroblastoma;   Anaplastic Oligodendroglioma;   Malignant Glioma
Intervention: Drug: Mebendazole
24 Terminated Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma;   Gliosarcoma
Interventions: Dietary Supplement: ascorbic acid;   Drug: temozolomide;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
25 Recruiting Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Ependymoma;   Anaplastic Oligodendroglioma;   Gliosarcoma;   Mixed Glioma;   Recurrent Adult Brain Neoplasm;   Recurrent Glioblastoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Lapatinib Ditosylate;   Other: Pharmacological Study;   Procedure: Therapeutic Conventional Surgery
26 Active, not recruiting Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
27 Active, not recruiting p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
Conditions: Teratoid Tumor, Atypical;   Choroid Plexus Neoplasms;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Brainstem Tumors;   Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma;   Medulloblastoma;   Neuroectodermal Tumor, Primitive
Intervention: Drug: azurin-derived cell-penetrating peptide p28
28 Recruiting Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
Conditions: Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma;   Brain Tumors;   Brain Cancer
Intervention:
29 Unknown  Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine;   Procedure: tumor resection surgery
30 Unknown  Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine(BCNU);   Procedure: Surgery
31 Active, not recruiting Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma;   Estrogen Receptor Negative;   Estrogen Receptor Positive;   Glioblastoma;   Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Metastatic Renal Cell Cancer;   Recurrent Adult Brain Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Colorectal Carcinoma;   Recurrent Esophageal Carcinoma;   Recurrent Gastric Carcinoma;   Recurrent Hepatocellular Carcinoma;   Recurrent Lung Carcinoma;   Recurrent Melanoma;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Resectable Hepatocellular Carcinoma;   Sarcoma;   Stage IA Breast Cancer;   Stage IA Ovarian Cancer;   Stage IA Uterine Corpus Cancer;   Stage IB Breast Cancer;   Stage IB Ovarian Cancer;   Stage IB Uterine Corpus Cancer;   Stage IC Ovarian Cancer;   Stage II Uterine Corpus Cancer;   Stage IIA Breast Cancer;   Stage IIA Lung Carcinoma;   Stage IIA Ovarian Cancer;   Stage IIB Breast Cancer;   Stage IIB Esophageal Cancer;   Stage IIB Lung Carcinoma;   Stage IIB Ovarian Cancer;   Stage IIB Skin Melanoma;   Stage IIC Ovarian Cancer;   Stage IIC Skin Melanoma;   Stage IIIA Breast Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIA Lung Carcinoma;   Stage IIIA Ovarian Cancer;   Stage IIIA Skin Melanoma;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Skin Melanoma;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Esophageal Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Skin Melanoma;   Stage IIIC Uterine Corpus Cancer;   Stage IV Bladder Urothelial Carcinoma;   Stage IV Esophageal Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Skin Melanoma;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sirolimus
32 Active, not recruiting Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
33 Completed
Has Results
BIBF 1120 for Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Drug: BIBF 1120
34 Completed AZD8055 for Adults With Recurrent Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Malignant Glioma;   Brainstem Glioma
Intervention: Drug: AZD8055
35 Terminated (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
Conditions: Low Grade Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Oligoastrocytoma
Intervention:
36 Active, not recruiting Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Giant Cell Glioblastoma;   Glioblastoma;   Gliosarcoma;   Mixed Glioma;   Recurrent Brain Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Montanide ISA-51/Survivin Peptide Vaccine;   Biological: Sargramostim
37 Completed
Has Results
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma
Interventions: Drug: ZD6474 (Vandetanib);   Drug: Carboplatin
38 Completed
Has Results
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma
Interventions: Biological: Bevacizumab;   Drug: MLN-518 (Tandutinib);   Procedure: Quality-of-life assessment
39 Terminated Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma
Intervention: Other: MRS Spectroscopy
40 Completed Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years